Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Coda Octopus price target raised to $11 from $10 at Alliance Global Partners » 12:07
03/16/23
03/16
12:07
03/16/23
12:07
CODA

Coda Octopus

$6.70 /

+0.37 (+5.85%)

Alliance Global Partners…

Alliance Global Partners analyst Brian Kinstlinger raised the firm's price target on Coda Octopus to $11 from $10 and keeps a Buy rating on the shares post the fiscal Q1 results. With the DAVD program moving to operational status, management expects to begin receiving DAVD orders in Q2, the analyst tells investors in a research note. The firm increased fiscal 2024 estimates to reflect a stronger than expected expected ramp from DAVD orders.

ShowHide Related Items >><<
CODA Coda Octopus
$6.70 /

+0.37 (+5.85%)

01/30/23 Alliance Global Partners
Coda Octopus price target raised to $10 from $8 at Alliance Global Partners
06/14/22 Alliance Global Partners
Alliance Global trims Coda Octopus target to $8 after lower-than-expected Q2
CODA Coda Octopus
$6.70 /

+0.37 (+5.85%)

Earnings
Coda Octopus reports Q1 EPS 12c vs. 11c last year » 06:10
03/16/23
03/16
06:10
03/16/23
06:10
CODA

Coda Octopus

$6.30 /

-0.425 (-6.32%)

Reports Q1 revenue $5.6M…

Reports Q1 revenue $5.6M vs. $5.8M last year.

ShowHide Related Items >><<
CODA Coda Octopus
$6.30 /

-0.425 (-6.32%)

01/30/23 Alliance Global Partners
Coda Octopus price target raised to $10 from $8 at Alliance Global Partners
06/14/22 Alliance Global Partners
Alliance Global trims Coda Octopus target to $8 after lower-than-expected Q2
Over a month ago
Recommendations
Coda Octopus price target raised to $10 from $8 at Alliance Global Partners » 12:36
01/30/23
01/30
12:36
01/30/23
12:36
CODA

Coda Octopus

$7.35 /

-0.78 (-9.59%)

Alliance Global Partners…

Alliance Global Partners analyst Brian Kinstlinger raised the firm's price target on Coda Octopus to $10 from $8 and keeps a Buy rating on the shares. The company reported Q4 revenue of $5.1M, which was about $500,000 lower than expected due to unfavorable foreign exchange rates and slower sales conversions, said the firm. Alliance, which fine-tuned its revenue estimates to reflect a stronger U.S. dollar and a slower conversion cycle, contends that Coda becoming a supplier to the original equipment makers of next generation of underwater vehicles "is a major catalyst" and Echoscope PIPE "seems to be on the path of becoming" the sensor of choice for defense primes in the process of building new underwater vehicles.

ShowHide Related Items >><<
CODA Coda Octopus
$7.35 /

-0.78 (-9.59%)

06/14/22 Alliance Global Partners
Alliance Global trims Coda Octopus target to $8 after lower-than-expected Q2
02/14/22 Alliance Global Partners
Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
Over a quarter ago
Recommendations
Alliance Global trims Coda Octopus target to $8 after lower-than-expected Q2 » 13:32
06/14/22
06/14
13:32
06/14/22
13:32
CODA

Coda Octopus

$4.99 /

-0.28 (-5.31%)

Alliance Global Partners…

Alliance Global Partners analyst Brian Kinstlinger lowered the firm's price target on Coda Octopus to $8 from $9 and keeps a Buy rating on the shares after the company reported Q2 revenue of $5M that implies a 7% year-over-year decline and was below his estimate. He thinks the primary driver of the shortfall was COVID in Europe that led to a significant decline in order conversion and remains confident that fundamentals will be "much stronger" in FY23, Kinstlinger tells investors.

ShowHide Related Items >><<
CODA Coda Octopus
$4.99 /

-0.28 (-5.31%)

CODA Coda Octopus
$4.99 /

-0.28 (-5.31%)

02/14/22 Alliance Global Partners
Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
10/05/21 Alliance Global Partners
Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
CODA Coda Octopus
$4.99 /

-0.28 (-5.31%)

CODA Coda Octopus
$4.99 /

-0.28 (-5.31%)

On The Fly
Fly Intel: Pre-market Movers » 09:02
06/14/22
06/14
09:02
06/14/22
09:02
CLR

Continental Resources

$64.48 /

-6.02 (-8.54%)

, KAVL

Kaival Brands

$1.71 /

+0.42 (+32.56%)

, CNM

Core & Main

$21.62 /

-0.84 (-3.74%)

, LICY

Li-Cycle

$6.81 /

-0.41 (-5.68%)

, SIOX

Sio Gene Therapies

/

+

, ORCL

Oracle

$64.07 /

-3.05 (-4.54%)

, CODA

Coda Octopus

$5.28 /

-0.33 (-5.88%)

, COIN

Coinbase

$52.02 /

-6.625 (-11.30%)

, DAWN

Day One Biopharmaceuticals

$14.96 /

+8.3 (+124.62%)

, OM

Outset Medical

$20.43 /

-0.585 (-2.78%)

, BBY

Best Buy

$69.51 /

-2.22 (-3.09%)

Check out this morning's…

ShowHide Related Items >><<
SIOX Sio Gene Therapies
/

+

ORCL Oracle
$64.07 /

-3.05 (-4.54%)

OM Outset Medical
$20.43 /

-0.585 (-2.78%)

LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

KAVL Kaival Brands
$1.71 /

+0.42 (+32.56%)

DAWN Day One Biopharmaceuticals
$14.96 /

+8.3 (+124.62%)

COIN Coinbase
$52.02 /

-6.625 (-11.30%)

CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

CNM Core & Main
$21.62 /

-0.84 (-3.74%)

CLR Continental Resources
$64.48 /

-6.02 (-8.54%)

BBY Best Buy
$69.51 /

-2.22 (-3.09%)

CLR Continental Resources
$64.48 /

-6.02 (-8.54%)

06/14/22 Barclays
Continental Resources price target raised to $77 from $67 at Barclays
04/25/22 Susquehanna
Continental Resources price target raised to $66 from $61 at Susquehanna
04/21/22 Truist
Continental Resources price target raised to $95 from $80 at Truist
04/19/22 Barclays
Continental Resources price target raised to $67 from $64 at Barclays
KAVL Kaival Brands
$1.71 /

+0.42 (+32.56%)

04/08/22 Maxim
Kaival Brands initiated with a Buy at Maxim
CNM Core & Main
$21.62 /

-0.84 (-3.74%)

03/31/22 Truist
Core & Main price target lowered to $28 from $32 at Truist
03/31/22 Barclays
Core & Main upgraded to Overweight from Equal Weight at Barclays
02/17/22 BofA
Core & Main downgraded to Underperform at BofA on 'modest' volume growth
02/17/22 BofA
Core & Main downgraded to Underperform from Neutral at BofA
LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

06/03/22 Morgan Stanley
Li-Cycle price target lowered to $8 from $10 at Morgan Stanley
04/07/22 Citi
Li-Cycle price target lowered to $10 from $11 at Citi
02/10/22 Morgan Stanley
Li-Cycle downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/22 Piper Sandler
Li-Cycle price target lowered to $15 from $18 at Piper Sandler
SIOX Sio Gene Therapies
/

+

04/28/22 H.C. Wainwright
Sio Gene Therapies downgraded to Sell from Buy at H.C. Wainwright
04/28/22 Cantor Fitzgerald
Sio Gene Therapies downgraded to Neutral from Overweight at Cantor Fitzgerald
02/02/22 BTIG
Sio Gene Therapies price target lowered to $3 from $8 at BTIG
02/01/22 SVB Securities
SVB Leerink downgrades Sio Gene Therapies to Market Perform, cuts target to $1
ORCL Oracle
$64.07 /

-3.05 (-4.54%)

06/14/22 JPMorgan
Oracle price target lowered to $82 from $100 at JPMorgan
06/14/22 BMO Capital
Oracle price target lowered to $86 from $92 at BMO Capital
06/14/22 Deutsche Bank
Oracle reported 'exceptional' Q4 results, says Deutsche Bank
06/14/22 Stifel
Oracle price target lowered to $72 from $83 at Stifel
CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

02/14/22 Alliance Global Partners
Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
10/05/21 Alliance Global Partners
Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
06/14/21 Alliance Global Partners
Coda Octopus price target raised to $13 from $11 at Alliance Global
COIN Coinbase
$52.02 /

-6.625 (-11.30%)

06/14/22 JPMorgan
JPMorgan downgrades Coinbase on 'extreme decline' in crypto markets
06/14/22 JPMorgan
Coinbase downgraded to Neutral from Overweight at JPMorgan
06/06/22 TD Cowen
Coinbase well capitalized to navigate 'crypto winter,' says Cowen
05/26/22 TD Cowen
Cowen says Coinbase 'built to last,' starts at Outperform
DAWN Day One Biopharmaceuticals
$14.96 /

+8.3 (+124.62%)

06/13/22 Wedbush
Day One Biopharmaceuticals price target raised to $35 from $32 at Wedbush
06/13/22 Piper Sandler
Piper reiterates $35 target on Day One after 'new high mark' data
06/13/22 JPMorgan
JPMorgan sees Day One shares moving to mid-teens, low-$20s on data
05/13/22 Wedbush
Day One Biopharmaceuticals removed from Best Ideas List at Wedbush
OM Outset Medical
$20.43 /

-0.585 (-2.78%)

06/14/22 TD Cowen
Outset Medical price target lowered to $33 from $60 at Cowen
06/14/22 Stifel
Outset Medical price target lowered to $30 from $55 at Stifel
03/02/22 BofA
Outset Medical reinstated with a Buy at BofA
02/17/22 Morgan Stanley
Outset Medical upgraded at Morgan Stanley on inflecting Home opportunity
BBY Best Buy
$69.51 /

-2.22 (-3.09%)

06/14/22 BofA
Tractor Supply upgraded to Buy at BofA as consumers shift spending
06/14/22 BofA
BofA cuts Best Buy to Neutral as consumers pull back on discretionary spending
06/14/22 BofA
Best Buy downgraded to Neutral from Buy at BofA
05/25/22 DA Davidson
Best Buy price target raised to $110 from $107 at DA Davidson
SIOX Sio Gene Therapies
/

+

ORCL Oracle
$64.07 /

-3.05 (-4.54%)

OM Outset Medical
$20.43 /

-0.585 (-2.78%)

LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

DAWN Day One Biopharmaceuticals
$14.96 /

+8.3 (+124.62%)

COIN Coinbase
$52.02 /

-6.625 (-11.30%)

CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

CNM Core & Main
$21.62 /

-0.84 (-3.74%)

CLR Continental Resources
$64.48 /

-6.02 (-8.54%)

BBY Best Buy
$69.51 /

-2.22 (-3.09%)

  • 15
    Jun
  • 06
    Jan
  • 30
    Sep
  • 23
    Jul
ORCL Oracle
$64.07 /

-3.05 (-4.54%)

LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

COIN Coinbase
$52.02 /

-6.625 (-11.30%)

SIOX Sio Gene Therapies
/

+

ORCL Oracle
$64.07 /

-3.05 (-4.54%)

LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

COIN Coinbase
$52.02 /

-6.625 (-11.30%)

CNM Core & Main
$21.62 /

-0.84 (-3.74%)

CLR Continental Resources
$64.48 /

-6.02 (-8.54%)

BBY Best Buy
$69.51 /

-2.22 (-3.09%)

ORCL Oracle
$64.07 /

-3.05 (-4.54%)

LICY Li-Cycle
$6.81 /

-0.41 (-5.68%)

DAWN Day One Biopharmaceuticals
$14.96 /

+8.3 (+124.62%)

COIN Coinbase
$52.02 /

-6.625 (-11.30%)

BBY Best Buy
$69.51 /

-2.22 (-3.09%)

Earnings
Coda Octopus reports Q2 EPS 6c vs. 20c a year ago » 06:03
06/14/22
06/14
06:03
06/14/22
06:03
CODA

Coda Octopus

$5.28 /

-0.33 (-5.88%)

Reports Q2 revenue $4.98M…

Reports Q2 revenue $4.98M vs. $5.37M a year ago. Annmarie Gayle, Coda's Chairman and CEO, commented: "Our financial results for the SQ2022 were not in-line with our internal Management Business Plan for the period or published Management Revenue Targets and were down over the comparable period last year. One of our key performance measures for our business is the level of proposals submitted to prospective customers for orders in the period. In the reporting period, our level of proposals submitted to customers has increased over the comparable SQ2021. We are therefore disappointed that the conversion of these opportunities into firm sales has been slower than anticipated in the SQ2022 period. We believe that some of the factors which are slowing down the placement of orders by our customers, particularly for our Services Business, relate to uncertainties arising from the supply chain where there is significant scarcity of components and raw materials in conjunction with sharp price increases. This results in multiple iterations of the same proposals, resulting in delay in the placement of these orders. In addition, we believe that the Pandemic has caused delays in receiving orders from Europe which has resulted in a sharp fall in revenues generated from Europe in the SQ2022 period compared to the SQ2021. Further details can be found in our Form 10-Q for the SQ2022 period."

ShowHide Related Items >><<
CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

02/14/22 Alliance Global Partners
Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
10/05/21 Alliance Global Partners
Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
06/14/21 Alliance Global Partners
Coda Octopus price target raised to $13 from $11 at Alliance Global
CODA Coda Octopus
$5.28 /

-0.33 (-5.88%)

Hot Stocks
Coda Octopus CFO Mike Midgley to retire, Nathan Parker to succeed » 06:08
05/31/22
05/31
06:08
05/31/22
06:08
CODA

Coda Octopus

$5.16 /

+0.01 (+0.19%)

Coda Octopus Group…

Coda Octopus Group announced the retirement of its current CFO, Mike Midgley who will formally leave his post in June 2022 and the appointment of Nathan Parker who will succeed Midgley as CFO, effective June 13. Parker will be based in Salt Lake City. Nathan Parker joins the Group as a well-qualified and experienced financial professional who will bring a number of additional skills to this role. From 2021 to 2022, Nathan was CFO for the Water Treatment business of Franklin Electric, a Fort Wayne Indiana based $2B global leading manufacturer and distributor of water and fuel systems for use across residential, commercial, agricultural, industrial, and municipal applications.

ShowHide Related Items >><<
CODA Coda Octopus
$5.16 /

+0.01 (+0.19%)

CODA Coda Octopus
$5.16 /

+0.01 (+0.19%)

02/14/22 Alliance Global Partners
Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
10/05/21 Alliance Global Partners
Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
06/14/21 Alliance Global Partners
Coda Octopus price target raised to $13 from $11 at Alliance Global
CODA Coda Octopus
$5.16 /

+0.01 (+0.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.